ES2191825T3 - Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia. - Google Patents

Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.

Info

Publication number
ES2191825T3
ES2191825T3 ES97909372T ES97909372T ES2191825T3 ES 2191825 T3 ES2191825 T3 ES 2191825T3 ES 97909372 T ES97909372 T ES 97909372T ES 97909372 T ES97909372 T ES 97909372T ES 2191825 T3 ES2191825 T3 ES 2191825T3
Authority
ES
Spain
Prior art keywords
metal salts
therapy
physiological action
biliary acids
biliary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97909372T
Other languages
English (en)
Inventor
Beniamino Palmieri
Alessandro Medici
Enzo Bartoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ice SRL
Original Assignee
Ice SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ice SRL filed Critical Ice SRL
Application granted granted Critical
Publication of ES2191825T3 publication Critical patent/ES2191825T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Abstract

Sales de ácidos biliares con un metal seleccionado entre el grupo constituido por hierro (III), cobre (I), cobre (II), zinc, cobalto, molibdeno, platino, oro, manganeso, vanadio, selenio, estaño, níquel.
ES97909372T 1997-10-09 1997-10-09 Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia. Expired - Lifetime ES2191825T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/005555 WO1999019342A1 (en) 1997-10-09 1997-10-09 Bile acid salts of metals with physiological action and the use thereof in therapy

Publications (1)

Publication Number Publication Date
ES2191825T3 true ES2191825T3 (es) 2003-09-16

Family

ID=8166756

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97909372T Expired - Lifetime ES2191825T3 (es) 1997-10-09 1997-10-09 Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.

Country Status (14)

Country Link
US (1) US6342489B1 (es)
EP (1) EP1023314B1 (es)
JP (1) JP2001519438A (es)
AT (1) ATE232541T1 (es)
AU (1) AU747019B2 (es)
CA (1) CA2305764C (es)
DE (1) DE69719095T2 (es)
DK (1) DK1023314T3 (es)
ES (1) ES2191825T3 (es)
HK (1) HK1032064A1 (es)
IL (2) IL135499A0 (es)
NO (1) NO314761B1 (es)
NZ (1) NZ503800A (es)
WO (1) WO1999019342A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1468922A1 (de) * 1965-06-30 1969-06-19 Riedel De Haen Ag Verfahren zur Herstellung choleretisch wirksamer Derivate der 3-alpha-Hydroxy-7,12-diketocholansaeure
US3620831A (en) * 1968-12-30 1971-11-16 Honeywell Inc Electrographic recording medium
GB1592791A (en) * 1977-01-07 1981-07-08 Radiochemical Centre Ltd Selenium- or tellurium-containing bile acids and derivatives thereof
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5174897A (en) * 1991-09-24 1992-12-29 The United States Of America As Represented By The Secretary Of Agriculture Constructed wetlands to control nonpoint source pollution
US5415872A (en) 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5460812A (en) 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
IL135499A0 (en) 2001-05-20
CA2305764A1 (en) 1999-04-22
ATE232541T1 (de) 2003-02-15
DK1023314T3 (da) 2003-05-12
NZ503800A (en) 2001-03-30
IL135499A (en) 2006-10-31
AU4708197A (en) 1999-05-03
CA2305764C (en) 2008-04-08
NO20001812L (no) 2000-04-07
DE69719095D1 (de) 2003-03-20
EP1023314A1 (en) 2000-08-02
JP2001519438A (ja) 2001-10-23
NO314761B1 (no) 2003-05-19
NO20001812D0 (no) 2000-04-07
US6342489B1 (en) 2002-01-29
DE69719095T2 (de) 2003-07-24
EP1023314B1 (en) 2003-02-12
HK1032064A1 (en) 2001-07-06
WO1999019342A1 (en) 1999-04-22
AU747019B2 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
TR199903034T2 (xx) Piperazin t�revleri ve anti-enflamatuvar ajan olarak kullan�mlar�.
RU94000061A (ru) Эфиры холестерина и ненасыщенных жирных кислот, способ лечения и фармацевтическая или косметическая композиция
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
DE69005950T2 (de) Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
PT902789E (pt) Derivados de androsteno
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
GB9723824D0 (en) Cytostatic agents
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่
IT8322170A0 (it) Composti atti al trattamento terapeutico delle alterazioni biliari, in particilare della bile litogena e dei calcoli colesterolici e composizioni farmaceutiche cheli contengono.